Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
C
|
Chipotle Mexican Grill Inc
XMUN:C9F
|
US |
|
Fossil Group Inc
NASDAQ:FOSL
|
US |
|
P
|
Pitney Bowes Inc
SWB:PBW
|
US |
|
D
|
Dr Ing hc F Porsche AG
XHAM:P911
|
DE |
|
BW Energy Ltd
OTC:BWEFF
|
BM |
|
W
|
Workhorse Group Inc
F:1WO
|
US |
|
A
|
Alector Inc
F:0Z2
|
US |
|
K
|
Kirin Holdings Co Ltd
XMUN:KIR
|
JP |
|
Vortex Energy Corp
F:AA3I
|
CA |
|
Acme United Corp
F:UT1
|
US |
|
T
|
Tele2 AB
DUS:NCYD
|
SE |
|
G
|
Greenrise Global Brands Inc
OTC:GRGBF
|
CA |
|
W
|
Weichai Power Co Ltd
XBER:WI4
|
CN |
|
E
|
Equifax Inc
SWB:EFX
|
US |
|
Andromeda Metals Ltd
ASX:ADN
|
AU |
|
I
|
Insmed Inc
F:IM8N
|
US |
|
ID Logistics SAS
LSE:0QAG
|
FR |
Wall St Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BM8 is 79.31 EUR with a low forecast of 44.05 EUR and a high forecast of 109.91 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
79.31
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 79.31 EUR with a low forecast of 44.05 EUR and a high forecast of 109.91 EUR.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.
